{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:56:21Z","timestamp":1775246181711,"version":"3.50.1"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The effects of half-sized secretory leukocyte protease inhibitor or diclofenac sodium administered alone or in combination with the benzoxazinorifamycin KRM-1648 on the therapeutic efficacy of KRM-1648 against\n                    <jats:italic>Mycobacterium avium<\/jats:italic>\n                    complex (MAC) in mice were studied. Neither of the two anti-inflammatory drugs affected the efficacy of KRM-1648, while they exerted significant modulating effects on tumor necrosis factor alpha production by MAC-infected macrophages.\n                  <\/jats:p>","DOI":"10.1128\/aac.43.2.360","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T20:34:13Z","timestamp":1539030853000},"page":"360-364","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Effects of Benzoxazinorifamycin KRM-1648 Administered Alone or in Combination with a Half-Sized Secretory Leukocyte Protease Inhibitor or the Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium against\n                    <i>Mycobacterium avium<\/i>\n                    Complex Infection in Mice"],"prefix":"10.1128","volume":"43","author":[{"given":"Chiaki","family":"Sano","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Microbiology and Immunology1 and"},{"name":"<!--label omitted: 2-->Department of Otorhinolaryngology,2 Shimane Medical University, Izumo, Shimane 693-8501, Japan, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Microbiology and Immunology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumasa","family":"Sato","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Microbiology and Immunology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kawauchi","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Otorhinolaryngology,2 Shimane Medical University, Izumo, Shimane 693-8501, Japan, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Kawahara","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Internal Medicine, National Sanatorium, Minami-Okayama Hospital,3 Okayama 701-0304, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruaki","family":"Tomioka","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Microbiology and Immunology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"478","article-title":"T cell-dependent chronic neutrophilia during mycobacterial infections.","volume":"78","author":"Appelberg R.","year":"1989","unstructured":"Appelberg R. Silva M. T. T cell-dependent chronic neutrophilia during mycobacterial infections. Clin. Exp. Immunol. 78 1989 478 483","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(96)80198-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinids\/17.1.7","article-title":"Mycobacterium avium complex infection in AIDS: advances in theory and practice.","volume":"17","author":"Benson C. A.","year":"1993","unstructured":"Benson C. A. Ellner J. J. Mycobacterium avium complex infection in AIDS: advances in theory and practice. Clin. Infect. Dis. 17 1993 7 20","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.4049\/jimmunol.150.5.1838","article-title":"Production of transforming growth factor-\u03b2 by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-\u03b3.","volume":"150","author":"Bermudez L. E.","year":"1993","unstructured":"Bermudez L. E. Production of transforming growth factor-\u03b2 by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-\u03b3. J. Immunol. 150 1993 1838 1845","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.7.3093-3097.1993"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4049\/jimmunol.140.9.3006","article-title":"Tumor necrosis factor, alone or in combination with IL-2, but not IFN-\u03b3, is associated with macrophage killing of Mycobacterium avium complex.","volume":"140","author":"Bermudez L. E.","year":"1988","unstructured":"Bermudez L. E. Young L. S. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-\u03b3, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140 1988 3006 3013","journal-title":"J. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-2952(96)00136-0","article-title":"Differential effects of Tenidap on the zymosan- and lipopolysaccharide-induced expression of mRNA for proinflammatory cytokines in macrophages.","volume":"52","author":"Bondeson J.","year":"1996","unstructured":"Bondeson J. Sundler R. Differential effects of Tenidap on the zymosan- and lipopolysaccharide-induced expression of mRNA for proinflammatory cytokines in macrophages. Biochem. Pharmacol. 52 1996 35 42","journal-title":"Biochem. Pharmacol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0952-7915(92)90082-P","article-title":"Interleukin-10.","volume":"4","author":"De Waal Malefyt R.","year":"1992","unstructured":"De Waal Malefyt R. Yssel H. Roncarolo M.-G. Spits H. de Vries J. E. Interleukin-10. Curr. Opin. Immunol. 4 1992 314 320","journal-title":"Curr. Opin. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4049\/jimmunol.145.3.940","article-title":"Macrophage deactivating factor and transforming growth factors \u03b21, \u03b22, \u03b23 inhibit induction of macrophage nitrogen oxide synthesis by IFN-\u03b3.","volume":"145","author":"Ding A.","year":"1990","unstructured":"Ding A. Nathan C. F. Graycar J. Derynck R. Stuehr D. J. Srimal S. Macrophage deactivating factor and transforming growth factors \u03b21, \u03b22, \u03b23 inhibit induction of macrophage nitrogen oxide synthesis by IFN-\u03b3. J. Immunol. 145 1990 940 944","journal-title":"J. Immunol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.2.177"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.4410-4413.1992"},{"key":"e_1_3_2_13_2","first-page":"505","article-title":"Bullous emphysema and Mycobacterium avium-intracellulare superinfection.","volume":"24","author":"Guichenez P.","year":"1995","unstructured":"Guichenez P. Berthelot P. Bour G. Charret F. Chaussinand J. P. Chanwar J. Bullous emphysema and Mycobacterium avium-intracellulare superinfection. Presse Med. 24 1995 505","journal-title":"Presse Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/intimm\/8.8.1299","article-title":"Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.","volume":"8","author":"Hansch H. C. R.","year":"1996","unstructured":"Hansch H. C. R. Smith D. A. Mielke M. E. A. Hahn H. Bancroft G. J. Ehlers S. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8 1996 1299 1310","journal-title":"Int. Immunol."},{"key":"e_1_3_2_15_2","first-page":"251","article-title":"The prostaglandin E1 analogue, Misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3.","volume":"76","author":"Haynes D. R.","year":"1992","unstructured":"Haynes D. R. Whitehouse M. W. Vernon-Roberts B. The prostaglandin E1 analogue, Misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 76 1992 251 257","journal-title":"Immunology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0962-8479(96)90070-2","article-title":"Clarithromycin against Mycobacterium avium complex infection.","volume":"77","author":"Heifets L. B.","year":"1996","unstructured":"Heifets L. B. Clarithromycin against Mycobacterium avium complex infection. Tubercle Lung Dis. 77 1996 19 26","journal-title":"Tubercle Lung Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0092-8674(00)81880-2","article-title":"Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.","volume":"88","author":"Jin F.","year":"1997","unstructured":"Jin F. Nathan C. Radzioch D. Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88 1997 417 426","journal-title":"Cell"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3565(25)12032-6","article-title":"New antiinflammatory compounds that inhibit tumor necrosis factor production: probable interaction with protein kinase C activation.","volume":"275","author":"Lang F.","year":"1995","unstructured":"Lang F. Robert J. M. Boucrot P Welin L. Petit J. Y. New antiinflammatory compounds that inhibit tumor necrosis factor production: probable interaction with protein kinase C activation. J. Pharm. Exp. Ther. 275 1995 171 176","journal-title":"J. Pharm. Exp. Ther."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/1043-4666(91)90501-4","article-title":"In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6.","volume":"3","author":"Marcinkiewicz J.","year":"1991","unstructured":"Marcinkiewicz J. In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6. Cytokine 3 1991 327 332","journal-title":"Cytokine"},{"key":"e_1_3_2_20_2","first-page":"A201","article-title":"Expression of the C-terminal domain of secretory leukoprotease inhibitor in E. coli as a thrombin-cleavable fusion protein.","volume":"145","author":"Masuda K.","year":"1992","unstructured":"Masuda K. Imaizumi A. Kamimura T. Watanabe K. Sugiyama T. Suzuki Y. Ohtsuka E. Expression of the C-terminal domain of secretory leukoprotease inhibitor in E. coli as a thrombin-cleavable fusion protein. Am. Rev. Respir. Dis. 145 1992 A201","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/ajrccm.153.1.8542145","article-title":"Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters.","volume":"153","author":"Mitsuhashi H.","year":"1997","unstructured":"Mitsuhashi H. Asano S. Nonaka T. Hamamura I. Masuda K. Kiyoki M. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Respir. Crit. Care Med. 153 1997 369 374","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1476-5381.1993.tb13511.x","article-title":"Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.","volume":"108","author":"Renesto P.","year":"1993","unstructured":"Renesto P. Balloy V. Kamimura T. Masuda K. Imaizumi A. Chignard M. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Br. J. Pharmacol. 108 1993 1100 1106","journal-title":"Br. J. Pharmacol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(90)90032-L"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0962-8479(95)90580-4","article-title":"Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.","volume":"76","author":"Saito H.","year":"1995","unstructured":"Saito H. Tomioka H. Sato K. Kawahara S. Hidaka T. Dekio S. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice. Tubercle Lung Dis. 76 1995 51 58","journal-title":"Tubercle Lung Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.11.6.7946401","article-title":"Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI\/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.","volume":"11","author":"Sallenave J.-M.","year":"1994","unstructured":"Sallenave J.-M. Shulmann J. Crossley J. Jordana M. Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI\/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11 1994 733 741","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/41.1.77","article-title":"Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.","volume":"41","author":"Sato K.","year":"1998","unstructured":"Sato K. Akaki T. Tomioka H. Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. J. Antimicrob. Chemother. 41 1998 77 83","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jlb.62.3.374","article-title":"Modulation of nitric oxide production in RAW 264.7 cells by transforming growth factor-beta and interleukin-10: differential effects on free and encapsulated immunomodulator.","volume":"62","author":"Seyler I.","year":"1997","unstructured":"Seyler I. Appel M. Devissaguet J.-P. Legrand P. Barratt G. Modulation of nitric oxide production in RAW 264.7 cells by transforming growth factor-beta and interleukin-10: differential effects on free and encapsulated immunomodulator. J. Leukocyte Biol. 62 1997 374 380","journal-title":"J. Leukocyte Biol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1099\/00221287-115-1-161","article-title":"Differing contribution of polymorphonuclear cells and macrophages to protection of mice against Listeria monocytogenes and Pseudomonas aeruginosa.","volume":"115","author":"Tatsukawa K.","year":"1979","unstructured":"Tatsukawa K. Mitsuyama M. Takeya K. Nomoto K. Differing contribution of polymorphonuclear cells and macrophages to protection of mice against Listeria monocytogenes and Pseudomonas aeruginosa. J. Gen. Microbiol. 115 1979 161 166","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.18.6692"},{"key":"e_1_3_2_30_2","first-page":"37","article-title":"In vitro and in vivo antimycobacterial activities of KRM-1648, a new benzoxazinorifamycin","volume":"2","author":"Tomioka H.","year":"1997","unstructured":"Tomioka H. Sato K. Hidaka T. Saito H. In vitro and in vivo antimycobacterial activities of KRM-1648, a new benzoxazinorifamycin Recent research developments in antimicrobial agents and chemotherapy Pandali S. G. 2 1997 37 68 Research Signpost Trivandrum, India","journal-title":"Recent research developments in antimicrobial agents and chemotherapy"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jlb.58.6.704","article-title":"The role of tumor necrosis factor, interferon-\u03b3, transforming growth factor-\u03b2, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.","volume":"58","author":"Tomioka H.","year":"1995","unstructured":"Tomioka H. Sato K. Maw W. W. Saito H. The role of tumor necrosis factor, interferon-\u03b3, transforming growth factor-\u03b2, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J. Leukocyte Biol. 58 1995 704 712","journal-title":"J. Leukocyte Biol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.41.2.357","article-title":"Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.","volume":"41","author":"Tomioka H.","year":"1997","unstructured":"Tomioka H. Sato K. Shimizu T. Sano C. Akaki T. Saito H. Fujii K. Hidaka T. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother. 41 1997 3573 362","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.1.224-228.1995"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1164\/ajrccm\/143.6.1412","article-title":"Potential problems in designing elastase inhibitors for therapy.","volume":"143","author":"Travis J.","year":"1991","unstructured":"Travis J. Fits H. Potential problems in designing elastase inhibitors for therapy. Am. Rev. Respir. Dis. 143 1991 1412 1415","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00918135","article-title":"Transforming growth factor beta (TGF-\u03b2) in inflammation: a cause and a cure.","volume":"12","author":"Wahl S. M.","year":"1992","unstructured":"Wahl S. M. Transforming growth factor beta (TGF-\u03b2) in inflammation: a cause and a cure. J. Clin. Immunol. 12 1992 61 73","journal-title":"J. Clin. Immunol."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.2.360","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.2.360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:01:55Z","timestamp":1775242915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.2.360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1128\/AAC.43.2.360"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.2.360","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"1998-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}